← Leaderboards
Kenneth J Kellar
Georgetown University
$5,397,634
Attributed
$5,397,634
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$9,655,504 · 5
By mechanism
U19$4,943,741 · 2
R01$4,362,563 · 2
R56$349,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Alan Paul Kozikowski$7,525,629
Others in their field
Top investigators on “Nicotine”
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$52,725,890
- Stephen T Higgins · University Of Vermont &St Agric College$41,481,617
- Neal L Benowitz · University Of California San Francisco$28,140,951
- Caryn Lerman · University Of Southern California$26,022,644
- Stephen S Hecht · University Of Minnesota$25,906,702
- Marina R. Picciotto · Yale University$25,752,267
Research focus
NicotineNicotinic ReceptorsPharmacologyAutonomic GanglionIn VivoPropertyReceptor BindingIonsNicotine DependenceProgress ReportsBrainLeadAreaDopamineReceptorBaseReceptor FunctionNeurotransmittersNeuronsAdoptedAgonistCholinergic ReceptorsAffectBinding (Molecular Function)
Grant awards (24)
Novel Ligands that Selectively Desensitize alpha4beta nAChRs for Smoking Cessatio$843,310
U19 · FY2014 · DA · contact PI
Administrative Core Management Plan$59,604
U19 · FY2014 · DA · contact PI
Novel Ligands that Selectively Desensitize alpha4beta nAChRs for Smoking Cessatio$813,169
U19 · FY2013 · DA · contact PI
Administrative Core Management Plan$41,210
U19 · FY2013 · DA · contact PI
Novel Ligands that Selectively Desensitize alpha4beta nAChRs for Smoking Cessatio$852,359
U19 · FY2012 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$462,844
R01 · FY2012 · DA · contact PI
Administrative Core Management Plan$60,017
U19 · FY2012 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$3,305
R01 · FY2012 · DA · contact PI
Novel Ligands that Selectively Desensitize alpha4beta nAChRs for Smoking Cessatio$857,670
U19 · FY2011 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$463,119
R01 · FY2011 · DA · contact PI
Administrative Core Management Plan$60,131
U19 · FY2011 · DA · contact PI
Novel Ligands that Selectively Desensitize alpha4beta nAChRs for Smoking Cessatio$891,362
U19 · FY2010 · DA · contact PI
Administrative Core Management Plan$464,909
U19 · FY2010 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$463,538
R01 · FY2010 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$454,584
R01 · FY2009 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$329,523
R01 · FY2008 · DA · contact PI
Pharmacology and Regulation of Nicotinic Receptor Subtypes$349,200
R56 · FY2007 · DA · contact PI
NICOTINIC RECEPTORS AUTONOMIC GANGLIA AND ADRENAL GLAND$349,200
R01 · FY2005 · DA
NICOTINIC RECEPTORS AUTONOMIC GANGLIA AND ADRENAL GLAND$402,356
R01 · FY2004 · DA
NICOTINIC RECEPTORS AUTONOMIC GANGLIA AND ADRENAL GLAND$349,200
R01 · FY2003 · DA
NICOTINIC RECEPTORS AUTONOMIC GANGLIA AND ADRENAL GLAND$53,156
R01 · FY2003 · DA
NICOTINIC RECEPTORS AUTONOMIC GANGLIA AND ADRENAL GLAND$349,200
R01 · FY2002 · DA
NICOTINIC RECEPTORS AUTONOMIC GANGLIA AND ADRENAL GLAND$349,950
R01 · FY2001 · DA
ANTAGONIST ACTIONS OF NICOTINE$332,588
R01 · FY2000 · DA